ENZO BIOCHEM, INC. Accounts Receivable
ENZO BIOCHEM, INC. had Accounts Receivable of $4.31 million as of 2025-04-30, per its 10-Q filed 2025-06-16.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2025-06-16
- 2025-04-30: Accounts Receivable, after Allowance for Credit Loss, Current $4.31M.
- 2025-01-31: Accounts Receivable, after Allowance for Credit Loss, Current $4.25M.
- 2024-10-31: Accounts Receivable, after Allowance for Credit Loss, Current $3.84M.
- 2024-08-01: Accounts Receivable, after Allowance for Credit Loss, Current $3.99M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2025-04-30 | $4.31M 10-Q · filed 2025-06-16 | |
| 2025-01-31 | $4.25M 10-Q · filed 2025-03-17 | |
| 2024-10-31 | $3.84M 10-Q · filed 2024-12-16 | |
| 2024-08-01 | $3.99M 10-Q · filed 2025-06-16 | |
| 2024-07-31 | $3.99M 10-Q · filed 2025-06-16 | |
| 2024-04-30 | $3.94M 10-Q · filed 2024-06-13 | |
| 2024-01-31 | $5.12M 10-Q · filed 2024-03-13 | |
| 2023-10-31 | $4.18M 10-Q · filed 2023-12-15 | |
| 2023-08-01 | $4.81M 10-Q · filed 2025-06-16 | |
| 2023-07-31 | $4.81M 10-K · filed 2024-10-29 | |
| 2023-04-30 | $9.64M 10-Q · filed 2023-06-14 | |
| 2023-02-01 | $10.87K 10-Q · filed 2023-06-14 | |
| 2023-01-31 | $10.87M 10-Q · filed 2023-03-20 | |
| 2022-10-31 | $11.52M 10-Q · filed 2022-12-12 | |
| 2022-08-01 | $4.76M 10-Q · filed 2024-06-13 | $11.52K 10-Q · filed 2023-06-14 |
| 2022-07-31 | $4.76M 10-K · filed 2023-11-03 | $11.52M 10-K · filed 2022-10-14 |
| 2022-04-30 | $11.76M 10-Q · filed 2022-06-09 | |
| 2022-02-01 | $15.32K 10-Q · filed 2023-06-14 | |
| 2022-01-31 | $15.32M 10-Q · filed 2022-03-14 | |
| 2021-10-31 | $11.33M 10-Q · filed 2021-12-15 | |
| 2021-08-01 | $10.20K 10-Q · filed 2023-06-14 | |
| 2021-07-31 | $10.20M 10-K · filed 2022-10-14 | |
| 2021-04-30 | $11.47M 10-Q · filed 2021-06-11 | |
| 2021-01-31 | $12.10M 10-Q · filed 2021-03-16 | |
| 2020-10-31 | $12.05M 10-Q · filed 2020-12-11 | |
| 2020-07-31 | $9.14M 10-K · filed 2021-10-12 | |
| 2020-04-30 | $6.82M 10-Q · filed 2020-06-09 | |
| 2020-01-31 | $8.91M 10-Q · filed 2020-03-06 | |
| 2019-10-31 | $9.88M 10-Q · filed 2019-12-10 | |
| 2019-07-31 | $10.74M 10-K · filed 2020-10-19 | |
| 2019-04-30 | $11.44M 10-Q · filed 2019-06-10 | |
| 2019-01-31 | $11.66M 10-Q · filed 2019-03-11 | |
| 2018-10-31 | $12.84M 10-Q · filed 2018-12-10 | |
| 2018-07-31 | $13.15M 10-K · filed 2020-10-19 | |
| 2018-04-30 | $14.41M 10-Q · filed 2018-06-11 | |
| 2018-01-31 | $14.98M 10-Q · filed 2018-03-12 | |
| 2017-10-31 | $14.44M 10-Q · filed 2017-12-07 | |
| 2017-07-31 | $15.18M 10-K · filed 2018-10-15 | |
| 2017-04-30 | $15.80M 10-Q · filed 2017-06-08 | |
| 2017-01-31 | $15.36M 10-Q · filed 2017-03-13 | |
| 2016-10-31 | $14.06M 10-Q · filed 2016-12-08 | |
| 2016-07-31 | $14.59M 10-K · filed 2017-09-27 | |
| 2016-04-30 | $14.00M 10-Q · filed 2016-06-08 | |
| 2016-01-31 | $12.88M 10-Q · filed 2016-03-09 | |
| 2015-10-31 | $12.76M 10-Q · filed 2015-12-08 | |
| 2015-07-31 | $12.11M 10-K · filed 2016-10-13 | |
| 2015-04-30 | $11.61M 10-Q · filed 2015-06-09 | |
| 2015-01-31 | $11.79M 10-Q · filed 2015-03-12 | |
| 2014-10-31 | $12.38M 10-Q · filed 2014-12-09 | |
| 2014-07-31 | $12.47M 10-K · filed 2015-10-13 | |
| 2014-04-30 | $12.31M 10-Q · filed 2014-06-09 | |
| 2014-01-31 | $11.86M 10-Q · filed 2014-03-11 | |
| 2013-10-31 | $13.72M 10-Q · filed 2013-12-10 | |
| 2013-07-31 | $12.29M 10-K · filed 2014-10-09 | |
| 2013-04-30 | $13.19M 10-Q · filed 2013-06-10 | |
| 2013-01-31 | $12.58M 10-Q · filed 2013-03-12 | |
| 2012-10-31 | $14.00M 10-Q · filed 2012-12-10 | |
| 2012-07-31 | $14.13M 10-K · filed 2013-10-15 | |
| 2012-04-30 | $13.89M 10-Q · filed 2012-06-11 | |
| 2012-01-31 | $13.40M 10-Q · filed 2012-03-12 | |
| 2011-10-31 | $14.67M 10-Q · filed 2011-12-12 | |
| 2011-07-31 | $15.24M 10-K · filed 2012-10-15 |